Drug Sequencing
Drug sequencing is a pharmacotherapeutic strategy that belongs to the class of treatment planning methods in oncology, specifically distinguished by the systematic ordering of pharmacological agents over time to optimize therapeutic efficacy, minimize resistance, and reduce toxicity in the management of genitourinary cancers.
48
Publications
2.5K
Citations
588
Authors
200
Institutions
Publications per year
2017–2026
19
48
Daniel Khalaf, Matti Annala, Sinja Taavitsainen et al. · The Lancet Oncology · 2019 · 352 citations
Medicine, Oncology, Pharmacotherapy +17
Helena Earl, Anne-Laure Vallier, Louise Hiller et al. · The Lancet Oncology · 2013 · 119 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 48
588
2
h-index
2
h-index
2
h-index
2
h-index
2
h-index
1–5 of 588
200
University of Cambridge
Cambridge, United Kingdom
3 h-index
10 publications
1.9K citations
Cambridge University Hospitals NHS Foundation Trust
Cambridge, United Kingdom
3 h-index
24 publications
3.2K citations
McKesson (United States)
San Francisco, United States
2 h-index
8 publications
244 citations

Royal Marsden NHS Foundation Trust
London, United Kingdom
2 h-index
27 publications
5.3K citations
Memorial Sloan Kettering Cancer Center
New York, United States
2 h-index
4 publications
726 citations
The University of Texas MD Anderson Cancer Center
Houston, United States
2 h-index
4 publications
140 citations
Harvard University
Cambridge, United States
2 h-index
3 publications
498 citations

Institute of Cancer Research
London, United Kingdom
2 h-index
25 publications
5.7K citations
1–8 of 200
Repository · 5 publications · 135 citations
5
h-index
4 publications · 216 citations
4
h-index
3 publications · 73 citations
3
h-index
2 publications · 471 citations
2
h-index
2 publications · 34 citations
2
h-index
1–5